binimetinib April 12, 2017 binimetinib Trade Name Orphan Indication Treatment Stage IIB-IV melanoma USA Market Approval USA USA Designation Date 2013-11-19 00:00:00 Sponsor Array BioPharma, Inc.;125 Cambridge Park Drive, Suite 301;Cambridge, Massachusetts, 02140
